137 related articles for article (PubMed ID: 38773987)
21. Improved waiting-list outcomes in Argentina after the adoption of a model for end-stage liver disease-based liver allocation policy.
Cejas NG; Villamil FG; Lendoire JC; Tagliafichi V; Lopez A; Krogh DH; Soratti CA; Bisigniano L
Liver Transpl; 2013 Jul; 19(7):711-20. PubMed ID: 23775946
[TBL] [Abstract][Full Text] [Related]
22. MELDEQ : An alternative Model for End-Stage Liver Disease score for patients with hepatocellular carcinoma.
Marvin MR; Ferguson N; Cannon RM; Jones CM; Brock GN
Liver Transpl; 2015 May; 21(5):612-22. PubMed ID: 25694099
[TBL] [Abstract][Full Text] [Related]
23. Are hepatocellular carcinoma patients more likely to receive liver resection in regions with longer transplant wait times?
Anderson JE; Hemming AW; Chang DC; Talamini MA; Mekeel KL
Transplant Proc; 2014; 46(1):199-201. PubMed ID: 24507051
[TBL] [Abstract][Full Text] [Related]
24. Outcomes of Liver Transplant Candidates with Primary Biliary Cholangitis: The Data from the Scientific Registry of Transplant Recipients.
Sayiner M; Stepanova M; De Avila L; Golabi P; Racila A; Younossi ZM
Dig Dis Sci; 2020 Feb; 65(2):416-422. PubMed ID: 31451982
[TBL] [Abstract][Full Text] [Related]
25. Patients From Appalachia Have Reduced Access to Liver Transplantation After Wait-Listing.
Beal EW; Tumin D; Sobotka L; Tobias JD; Hayes D; Pawlik TM; Washburn K; Mumtaz K; Conteh L; Black SM
Prog Transplant; 2018 Dec; 28(4):305-313. PubMed ID: 30205758
[TBL] [Abstract][Full Text] [Related]
26. Liver transplantation in Spain.
de la Rosa G; Fondevila C; Navasa M
Liver Transpl; 2016 Sep; 22(9):1259-64. PubMed ID: 27197947
[TBL] [Abstract][Full Text] [Related]
27. Prioritization for liver transplantation using the MELD score in Chile: Inequities generated by MELD exceptions.: A collaboration between the Chilean Liver Transplant Programs, the Public Health Institute and the National Transplant Coordinator.
Díaz LA; Norero B; Lara B; Robles C; Elgueta S; Humeres R; Poniachik J; Silva G; Wolff R; Innocenti F; Rojas JL; Zapata R; Hunter B; Álvarez S; Cancino A; Ibarra J; Rius M; González S; Calabrán L; Pérez RM
Ann Hepatol; 2019; 18(2):325-330. PubMed ID: 31010794
[TBL] [Abstract][Full Text] [Related]
28. Impact of Italian Score for Organ Allocation System on Deceased Donor Liver Transplantation: A Monocentric Competing Risk Time-to-Event Analysis.
Khouzam S; Pagano D; Barbàra M; Cintorino D; Li Petri S; di Francesco F; Ricotta C; Bonsignore P; Seidita A; Calamia S; Canzonieri M; Tropea A; Gruttadauria S
Transplant Proc; 2019 Nov; 51(9):2860-2864. PubMed ID: 31711575
[TBL] [Abstract][Full Text] [Related]
29. Prospective validation of a new priority allocation model for liver transplant candidates: an interim analysis.
Vitale A; Saracino E; D'Amico FE; Grigoletto F; Burra P; Angeli P; Boccagni P; Brolese A; Zanus G; Neri D; Gringeri E; D'Amico F; Valmasoni M; Carraro A; Gambato M; Feltracco P; Romano A; Buggio M; D'Amico DF; Cillo U
Transplant Proc; 2009 May; 41(4):1092-5. PubMed ID: 19460489
[TBL] [Abstract][Full Text] [Related]
30. NASH Leading Cause of Liver Transplant in Women: Updated Analysis of Indications For Liver Transplant and Ethnic and Gender Variances.
Noureddin M; Vipani A; Bresee C; Todo T; Kim IK; Alkhouri N; Setiawan VW; Tran T; Ayoub WS; Lu SC; Klein AS; Sundaram V; Nissen NN
Am J Gastroenterol; 2018 Nov; 113(11):1649-1659. PubMed ID: 29880964
[TBL] [Abstract][Full Text] [Related]
31. Predictors of low risk for dropout from the liver transplant waiting list for hepatocellular carcinoma in long wait time regions: Implications for organ allocation.
Mehta N; Dodge JL; Hirose R; Roberts JP; Yao FY
Am J Transplant; 2019 Aug; 19(8):2210-2218. PubMed ID: 30861298
[TBL] [Abstract][Full Text] [Related]
32. Liver Transplantation for Hepatic Epithelioid Hemangioendothelioma Is Facilitated by Exception Points With Acceptable Long-term Outcomes.
Brahmbhatt M; Prenner S; Bittermann T
Transplantation; 2020 Jun; 104(6):1187-1192. PubMed ID: 31577674
[TBL] [Abstract][Full Text] [Related]
33. Patients With Hepatocellular Carcinoma Have Highest Rates of Wait-listing for Liver Transplantation Among Patients With End-Stage Liver Disease.
Goldberg D; French B; Newcomb C; Liu Q; Sahota G; Wallace AE; Forde KA; Lewis JD; Halpern SD
Clin Gastroenterol Hepatol; 2016 Nov; 14(11):1638-1646.e2. PubMed ID: 27374003
[TBL] [Abstract][Full Text] [Related]
34. Validation of a dropout assessment model of candidates with/without hepatocellular carcinoma on a common liver transplant waiting list.
Toso C; Majno P; Berney T; Morel P; Mentha G; Combescure C
Transpl Int; 2014 Jul; 27(7):686-95. PubMed ID: 24649861
[TBL] [Abstract][Full Text] [Related]
35. The association of pretransplant ferritin level with waiting list and post-transplant survival. Does ferritin actually predict outcome?
Al-Freah MA; Kriese S; Foxton MR; Quaglia A; Bomford A; Heaton ND; O'Grady JG; Agarwal K; Wendon JA; Heneghan MA
Transpl Int; 2013 Nov; 26(11):1070-9. PubMed ID: 24138201
[TBL] [Abstract][Full Text] [Related]
36. Differences in access to liver transplantation: disease severity, waiting time, and transplantation center volume.
Ahmad J; Bryce CL; Cacciarelli T; Roberts MS
Ann Intern Med; 2007 May; 146(10):707-13. PubMed ID: 17502631
[TBL] [Abstract][Full Text] [Related]
37. Hepatitis C virus related cirrhosis decreased as indication to liver transplantation since the introduction of direct-acting antivirals: A single-center study.
Ferrarese A; Germani G; Gambato M; Russo FP; Senzolo M; Zanetto A; Shalaby S; Cillo U; Zanus G; Angeli P; Burra P
World J Gastroenterol; 2018 Oct; 24(38):4403-4411. PubMed ID: 30344424
[TBL] [Abstract][Full Text] [Related]
38. Racial Disparities in Candidates for Hepatocellular Carcinoma Liver Transplant After 6-Month Wait Policy Change.
Saberi B; Gurakar A; Tamim H; Schneider CV; Sims OT; Bonder A; Fricker Z; Alqahtani SA
JAMA Netw Open; 2023 Nov; 6(11):e2341096. PubMed ID: 37917059
[TBL] [Abstract][Full Text] [Related]
39. Gender disparity in liver transplant waiting-list mortality: the importance of kidney function.
Mindikoglu AL; Regev A; Seliger SL; Magder LS
Liver Transpl; 2010 Oct; 16(10):1147-57. PubMed ID: 20879013
[TBL] [Abstract][Full Text] [Related]
40. More Severe Deficits in Performance Status at Time of Liver Transplant is Associated With Significantly Higher Risk of Death Following Liver Transplantation.
McCabe P; Gish RG; Cheung R; Wong RJ
J Clin Gastroenterol; 2019 Oct; 53(9):e392-e399. PubMed ID: 30762610
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
